Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12614]
Articles [173]
Editorials [5]
Conferences [246]
elearning [17]
Use of T-VEC in early metastatic melanoma
Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
Use of T-VEC in early metastatic melanoma ( Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC
Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC ( Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA )
21 Oct 2018
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic...
Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York...
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma ( Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )
21 Oct 2018
Comment: Radiotherapy as a treatment option for metastatic prostate cancer
Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Comment: Radiotherapy as a treatment option for metastatic prostate cancer ( Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain )
21 Oct 2018
JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma
Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2018
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2018
Survival results from STAMPEDE, radiotherapy for prostate cancer
Dr Chris C. Parker - The Royal Marsden, London, UK
Survival results from STAMPEDE, radiotherapy for prostate cancer ( Dr Chris C. Parker - The Royal Marsden, London, UK )
21 Oct 2018
The past, present and future of treating ovarian cancer
Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
21 Oct 2018
Comment on SOLO-1 for advanced ovarian cancer
Dr Jonathan Ledermann - University College London, London, UK
Comment on SOLO-1 for advanced ovarian cancer ( Dr Jonathan Ledermann - University College London, London, UK )
21 Oct 2018
Olaparib improves progression free survival up front in ovarian cancer
Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
21 Oct 2018
A novel bifunctional fusion protein for combatting lung cancer
Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain
A novel bifunctional fusion protein for combatting lung cancer ( Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain )
21 Oct 2018
Comment on new treatment options for breast cancer
Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany
Comment on new treatment options for breast cancer ( Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany )
20 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation